S Korea’s IMM to buy Kolmar Holdings’ pharma contract manufacturing, drug biz for $413m

S Korea’s IMM to buy Kolmar Holdings’ pharma contract manufacturing, drug biz for $413m

Seoul, South Korea. Photo by Jana Sabeth Schultz on Unsplash

28 May, 2020

IMM Private equity Kolmar korea holdings

Printed by Unregistered user on Sat, 12 Jul 2025 06:07:58 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

S Korea's IMM PE to hit final close of fourth fund by H1 2020, may exceed target

South Korea’s IMM PE collects $1.3b for fourth fund

Read more from Rest of Asia

Brookfield, Stonepeak and Air Liquide shortlisted for Macquarie’s $3.6b S. Korean gas firm

MUFG targets US to ramp up global securitisation business